Clinical Trials
15 trialsNCT06480552 2026-06-04
An Open-label Dose Escalation/Expansion Trial to Evaluate the Safety and Anti-tumor Activity of TEV-56278 Alone or in Combination With Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors
Teva Branded Pharmaceutical Products R&D, Inc.
Phase 1 Recruiting
NCT06596473 2026-06-04
A Study of BG-C477 in Participants With Advanced Solid Tumors
BeOne Medicines
Phase 1 Recruiting
NCT07042100 2026-06-03
A Study to Test the Safety and Tolerability of SBO-154 in Patients With Advanced Solid Tumors.
Sun Pharma Advanced Research Company Limited
Phase 1 Recruiting
NCT07077434 2026-06-03
A Study to Assess Safety, Tolerability and Drug Levels of Navlimetostat (BMS-986504) in Participants With Advanced Solid Tumors
Bristol-Myers Squibb
Phase 1 Recruiting
NCT07387068 2026-06-02
Trial to Evaluate the Safety and Preliminary Efficacy of GEN1079 in Participants With Advanced Solid Tumors
Genmab
Phase 1 Recruiting
NCT07524348 2026-06-01
A Trial to Investigate the Safety of E303 in Participants With Advanced Refractory Solid Tumors
Samsung Bioepis Co., Ltd.
Phase 1 Recruiting
NCT06167317 2026-05-28
Study of GS-0201 Alone and in Combination in Participants With Advanced Solid Tumors
Gilead Sciences
Phase 1 Recruiting
NCT05067283 2026-05-26
KANDLELIT-001
Merck Sharp & Dohme LLC
Phase 1 Recruiting
NCT05277168 2026-05-22
A TRIAL TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND EFFICACY OF SHR-A1904 IN SUBJECTS WITH ADVANCED SOLID TUMORS
Jiangsu HengRui Medicine Co., Ltd.
Phase 1/2 Recruiting
NCT07596693 2026-05-19
KXV01 Injection in Patients With Advanced Solid Tumor (Including Osteosarcoma and Sarcoma)
TCRx Therapeutics Co.Ltd
Phase 1 Recruiting
NCT06400485 2026-05-18
AMT-676 in Patients With Advanced Solid Tumors
Multitude Therapeutics Inc.
Phase EARLY_PHASE1 Recruiting
NCT07459998 2026-05-18
SKB103 for Injection in Advanced Solid Tumors
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Phase 1/2 Recruiting
NCT07589530 2026-05-15
SOLID-NK
Beijing Biotech
Phase 1/2 Recruiting
NCT06739291 2026-05-14
A Study of SIGX1094R in Patients With Advanced Solid Tumors
Signet Therapeutics
Phase 1 Recruiting
NCT07172919 2026-05-14
A Rollover Study Evaluating Sotorasib With or Without Panitumumab in Participants With KRAS p.G12C Mutation
Amgen
Phase 2 Recruiting